Repurposing the natural compounds as potential therapeutic agents for COVID-19 based on the molecular docking study of the main protease and the receptor-binding domain of spike protein

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) enters the cell by interacting with the human angiotensin-converting enzyme 2 (ACE2) receptor through the receptor-binding domain (RBD) of spike (S) protein. In the cell, the viral 3-chymotrypsin-like cysteine protease (3CLpro) enzyme is ess...

Descripción completa

Detalles Bibliográficos
Autor principal: Eskandari, Vajiheh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110024/
https://www.ncbi.nlm.nih.gov/pubmed/35578055
http://dx.doi.org/10.1007/s00894-022-05138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110024/
https://www.ncbi.nlm.nih.gov/pubmed/35578055
http://dx.doi.org/10.1007/s00894-022-05138-3

Ejemplares similares